Non-COVID Sales Boost Exact Sciences’ Q1 Revenue; Revises FY22 Guidance
Exact Sciences Corp’s (NASDAQ:EXAS) Q1 revenues increased 21% Y/Y to $486.6 million, beating the average Wall Street estimate of $461.71…
Here’s How Much $1000 Invested In Exact Sciences 20 Years Ago Would Be Worth Today
Exact Sciences (NASDAQ:EXAS) has outperformed the market over the past 20 years by 2.83% on an annualized basis producing an average annual return of 10.04%. Currently, Exact Sciences has a market capitalization of $11.93 billion.
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much
Exact Sciences (NASDAQ:EXAS) has outperformed the market over the past 5 years by 12.08% on an annualized basis.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 454 stocks hit new 52-week lows.
Where Exact Sciences Stands With Analysts
Over the past 3 months, 4 analysts have published their opinion on Exact Sciences (NASDAQ:EXAS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Exact Sciences Clocks 16% Jump In Q4 Non-COVID-19 Revenues
Exact Sciences Corp's (NASDAQ: EXAS) Q4 revenues increas
Wells Fargo Maintains Equal-Weight on Exact Sciences, Lowers Price Target to $80
Wells Fargo analyst Dan Leonard maintains Exact Sciences (NASDAQ:EXAS) with a Equal-Weight and lowers the price target from $95 to $80.
Citigroup Maintains Neutral on Exact Sciences, Lowers Price Target to $80
Citigroup analyst Patrick Donnelly maintains Exact Sciences (NASDAQ:EXAS) with a Neutral and lowers the price target from $100 to $80.
Exact Sciences Q4 EPS $(1.28) Misses $(1.04) Estimate, Sales $473.81M Beat $449.00M Estimate
Exact Sciences (NASDAQ:EXAS) reported quarterly losses of $(1.28) per share which missed the analyst consensus estimate of $(1.04) by 23.08 percent. This is a 753.33 percent decrease over losses of $(0.15) per share from
Earnings Scheduled For February 22, 2022
Companies Reporting Before The Bell
• Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million.